Inimex Pharmaceuticals is a clinical-stage company focused on the development and commercialization of innate defense regulators.
Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body's innate defenses without causing inflammation.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 2, 2008 | Series B | $22M | 2 | — | — | Detail |
| Dec 8, 2004 | Series A | $2M | 2 |
British Columbia Discovery Fund
|
— | Detail |
| Jul 6, 2004 | Series A | $4.50M | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
British Columbia Discovery Fund
|
Yes | Series A |
Canadian Medical Discoveries Fund
|
— | Series B |
BC Advantage Funds
|
— | Series B |